Radiopharmaceuticals, also known as radioligand therapies, are a groundbreaking class of drugs that use radioactive isotopes to target and treat cancer. These innovative therapies offer new hope for patients by providing more targeted and effective treatment options.
Below is a list of approved radioligand therapies specifically indicated for cancer treatment:
Indications: Treatment of prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer.
Diseases: Prostate cancer.
Benefits: Lutetium-177 Vipivotide Tetraxetan targets PSMA-positive cancer cells, delivering radiation directly to the tumor. This targeted therapy helps to control the spread of cancer and improve survival rates for patients with advanced prostate cancer.
Find a treatment center that offers Pluvicto on AdvancedTherapiesConnect
